Cue Biopharma Stock Options Expiring on 15th of August
| CUE Stock | USD 0.88 0.02 2.21% |
Cue Biopharma's latest option contracts expiring on August 15th 2025 are carrying combined implied volatility of 4.38. The Cue Biopharma option chain provides detailed quote and price information for the current Cue Biopharma option contracts. It shows all of Cue Biopharma's listed puts, calls, expiration dates, strike prices, and other pricing information.
Cue Biopharma's stock options are financial instruments that give investors the right to buy or sell shares of Cue Biopharma common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Cue stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Cue Biopharma's stock price goes up or down, the stock options follow.
At present, Cue Biopharma's Stock Based Compensation is projected to increase significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 22.2 M, whereas Common Stock Total Equity is forecasted to decline to about 26.3 K. Cue Current Options Market Mood
Cue Biopharma's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Cue Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Unfortunately, most Cue Biopharma's options investors are not very successful. Cue Biopharma's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Cue contract
Base on the Rule 16, the options market is currently suggesting that Cue Biopharma will have an average daily up or down price movement of about 0.27% per day over the life of the 2025-08-15 option contract. With Cue Biopharma trading at USD 0.88010001, that is roughly USD 0.002409. If you think that the market is fully incorporating Cue Biopharma's daily price movement you should consider buying Cue Biopharma options at the current volatility level of 4.38%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Cue Biopharma Option Chain
When Cue Biopharma's strike price is surpassing the current stock price, the option contract against Cue Biopharma stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Cue Biopharma's option chain is a display of a range of information that helps investors for ways to trade options on Cue. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Cue. It also shows strike prices and maturity days for a Cue Biopharma against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | CUE250815C00004000 | 0 | 4.0 | 0.0 - 0.75 | 0.75 | |
Call | CUE250815C00003000 | 0 | 3.0 | 0.0 - 0.75 | 0.75 | |
Call | CUE250815C00002000 | 48 | 2.0 | 0.0 - 0.05 | 0.1 | Out |
Call | CUE250815C00001000 | 106 | 1.0 | 0.0 - 0.1 | 0.05 | Out |
Put | CUE250815P00004000 | 0 | 4.0 | 2.85 - 3.5 | 2.85 | In |
Put | CUE250815P00003000 | 0 | 3.0 | 1.85 - 2.5 | 1.85 | In |
Put | CUE250815P00002000 | 0 | 2.0 | 0.0 - 1.55 | 1.55 | In |
Put | CUE250815P00001000 | 0 | 1.0 | 0.0 - 0.55 | 0.55 | In |
Cue Biopharma Market Cap Over Time
Market Cap |
| Timeline |
Cue Total Stockholder Equity
Total Stockholder Equity |
|
Cue Biopharma Corporate Management
| MSE JD | General VP | Profile | |
| JD MSc | CEO Director | Profile | |
| Kenneth MD | Acting Officer | Profile | |
| Dr III | CoFounder | Profile | |
| Lucinda Warren | Chief Officer | Profile | |
| KerriAnn CPA | Chief Officer | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cue Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For information on how to trade Cue Stock refer to our How to Trade Cue Stock guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cue Biopharma. If investors know Cue will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cue Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.64) | Revenue Per Share | Quarterly Revenue Growth (0.76) | Return On Assets | Return On Equity |
The market value of Cue Biopharma is measured differently than its book value, which is the value of Cue that is recorded on the company's balance sheet. Investors also form their own opinion of Cue Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Cue Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cue Biopharma's market value can be influenced by many factors that don't directly affect Cue Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cue Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cue Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cue Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.